New dental products show their chops

The medication is broadly approved for heart failure with preserved or reduced ejection fraction.

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

Otsuka America Pharmaceutical and Lundbeck’s Alify Asimtufii (aripiprazole) also was approved for maintenance monotherapy treatment of bipolar I disorder in adults.

The drug treats amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).

Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.

From medication to legislation, multiple developments have advanced the pharmacy profession this year.